Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China flag China · Delayed Price · Currency is CNY
16.88
+0.13 (0.78%)
Mar 5, 2026, 3:04 PM CST

SHE:300003 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Jan '22 Dec '20
30,48820,90430,09542,50640,55748,711
Market Cap Growth
54.43%-30.54%-29.20%4.81%-16.74%-16.77%
Enterprise Value
34,08724,46231,24743,01042,91052,340
Last Close Price
16.8811.1215.2721.3820.7524.74
PE Ratio
72.9984.6523.9219.2923.5927.03
Forward PE
26.5720.2513.7622.0914.6022.12
PS Ratio
4.873.433.774.013.816.06
PB Ratio
1.721.251.722.603.304.62
P/TBV Ratio
2.952.192.834.075.968.52
P/FCF Ratio
42.43275.70206.5722.5419.5232.70
P/OCF Ratio
23.0228.4630.3915.2313.2523.31
EV/Sales Ratio
5.454.013.924.054.036.51
EV/EBITDA Ratio
25.0526.3915.3113.4214.2821.24
EV/EBIT Ratio
44.7557.1619.6115.3916.4325.22
EV/FCF Ratio
47.44322.62214.4822.8120.6535.14
Debt / Equity Ratio
0.330.350.280.270.390.51
Debt / EBITDA Ratio
4.285.842.331.321.582.16
Debt / FCF Ratio
8.1176.1033.712.302.333.58
Net Debt / Equity Ratio
0.110.110.02-0.090.090.27
Net Debt / EBITDA Ratio
1.451.920.20-0.440.351.17
Net Debt / FCF Ratio
2.6323.442.85-0.740.501.93
Asset Turnover
0.250.250.320.470.550.47
Inventory Turnover
1.191.181.311.912.482.19
Quick Ratio
1.281.641.741.511.741.00
Current Ratio
1.892.342.482.022.441.37
Return on Equity (ROE)
2.34%1.15%7.63%15.68%15.61%20.25%
Return on Assets (ROA)
1.88%1.08%4.02%7.73%8.40%7.61%
Return on Invested Capital (ROIC)
3.31%2.05%8.06%16.99%16.21%13.85%
Return on Capital Employed (ROCE)
3.70%2.00%7.50%14.60%15.00%15.60%
Earnings Yield
1.40%1.18%4.18%5.18%4.24%3.70%
FCF Yield
2.36%0.36%0.48%4.44%5.12%3.06%
Dividend Yield
1.61%2.49%2.17%1.59%1.32%0.92%
Payout Ratio
159.48%401.27%61.09%28.84%34.14%33.21%
Buyback Yield / Dilution
0.49%0.74%-2.48%-0.50%-1.75%-0.37%
Total Shareholder Return
2.08%3.23%-0.31%1.09%-0.42%0.55%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.